Every pharmaceutical site relies heavily on data, from building management systems monitoring operations to production figures influencing financial decisions. Interpreting this data is critical to measuring real-time energy consumption, identifying opportunities to reduce or reuse energy, and lowering greenhouse gas (GHG) emissions. Adding to the complexity, this data must be translated into actionable financial insights when seeking capital investment. In this presentation, we will highlight a case study of a pharmaceutical facility where a $10 million CAPEX investment led to a 67% reduction in Scope 1 emissions within a year, delivering over $1 million in annual OPEX savings. A comprehensive site-wide audit was conducted, moving “behind the meter” to provide the client’s engineering team with a detailed breakdown of energy usage by form and the corresponding GHG emissions across all systems. This process generated a series of opportunities, prioritized based on corporate and site sustainability targets, CAPEX, OPEX, and ROI. Due to the success of this project, the model has been replicated across three more sites, driving cultural change throughout its global operations—from the plant room to the boardroom. In this session, we aim to share our experiences from a designer's perspective including the challenges, successes, and lessons learned.
Session type
Schedule
Off